8-12 months after phase 1 completion. Next year
Also don’t really care because after GLP and Phase 1 studies coming up plus Walter Reed the company would be significantly de risked heading into phase 2 and the market cap will be a 100 million dollar market cap like its peers.
Keep posting. Apparently the FDA does not recognise the phase 1 studies completed in Australia lol you and Hawk70 should hold hands because AGN submitted its data in a similar fashion.
8-12 months after phase 1 completion. Next year Also don’t...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.010(13.7%) |
Mkt cap ! $14.89M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.3¢ | 7.3¢ | $10.79K | 139.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 57611 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 8639 | 2 |
View Market Depth
| Last trade - 10.32am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.3¢ |
Change
0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.7¢ | 7.3¢ | 77551 | ||
| Last updated 10.19am 04/06/2024 ? | |||||
| NYR (ASX) Chart |